|
AIP |
aryl hydrocarbon receptor interacting protein |
cancer: multiple endocrine neoplasia |
|
APC |
adenomatous polyposis coli |
cancer: FAP, MAP |
|
ATM |
ATM serine/threonine kinase |
cancer |
|
AXIN2 |
axin 2 |
cancer: CRC |
|
BARD1 |
BRCA1 associated RING domain 1 |
cancer |
|
BLM |
Bloom syndrome, RecQ helicase-like |
cancer |
|
BMPR1A |
bone morphogenetic protein receptor, type IA |
cancer: CRC, polyposis |
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
cancer: other CRC-related |
|
BRCA1 |
breast cancer 1, early onset |
cancer: ovary |
|
BRCA2 |
breast cancer 2, early onset |
cancer: ovary |
|
BRIP1 |
BRCA1 interacting protein C-terminal helicase 1 |
cancer: ovary |
|
CASR |
calcium-sensing receptor |
cancer: multiple endocrine neoplasia |
|
CDC73 |
cell division cycle 73 |
cancer: multiple endocrine neoplasia |
|
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
cancer: other CRC-related |
|
CDK4 |
cyclin-dependent kinase 4 |
cancer |
|
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
cancer: multiple endocrine neoplasia |
|
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
cancer: multiple endocrine neoplasia |
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
cancer: other CRC-related |
|
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
cancer: multiple endocrine neoplasia |
|
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
cancer: multiple endocrine neoplasia |
|
CDKN2D |
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
cancer |
|
CHEK1 |
checkpoint kinase 1 |
cancer |
|
CHEK2 |
checkpoint kinase 2 |
cancer: other CRC-related |
|
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
cancer: other CRC-related |
|
DHFR |
dihydrofolate reductase |
cancer |
|
ENG |
endoglin |
cancer: CRC, polyposis |
|
EPCAM |
epithelial cell adhesion molecule |
cancer: CRC, other CRC-related, ovary |
|
EXO1 |
exonuclease 1 |
cancer: CRC |
|
FAM175A |
family with sequence similarity 175, member A |
cancer |
|
FANCC |
Fanconi anemia, complementation group C |
cancer |
|
FH |
fumarate hydratase |
cancer: kidney |
|
FLCN |
folliculin |
cancer: other CRC-related, kidney |
|
GALNT12 |
polypeptide N-acetylgalactosaminyltransferase 12 |
cancer: other CRC-related |
|
GNAS |
GNAS complex locus |
cancer: multiple endocrine neoplasia |
|
HOXB13 |
homeobox B13 |
cancer |
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
cancer: other CRC-related |
|
MCC |
mutated in colorectal cancers |
cancer: other CRC-related |
|
MEN1 |
multiple endocrine neoplasia I |
cancer: multiple endocrine neoplasia |
|
MET |
MET proto-oncogene, receptor tyrosine kinase |
cancer: kidney |
|
MGMT |
O-6-methylguanine-DNA methyltransferase |
cancer: other CRC-related |
|
MLH1 |
mutL homolog 1 |
cancer: CRC |
|
MLH3 |
mutL homolog 3 |
cancer: CRC |
|
MRE11A |
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) |
cancer |
|
MSH2 |
mutS homolog 2 |
cancer: CRC |
|
MSH3 |
mutS homolog 3 |
cancer: CRC |
|
MSH6 |
mutS homolog 6 |
cancer: CRC |
|
MUTYH |
mutY homolog |
cancer: CRC, FAP |
|
NBN |
nibrin |
cancer |
|
NF1 |
neurofibromin 1 |
cancer: CRC |
|
NF2 |
neurofibromin 2 (merlin) |
cancer: CRC |
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
cancer: multiple endocrine neoplasia |
|
OGG1 |
8-oxoguanine DNA glycosylase |
cancer: other CRC-related |
|
PALB2 |
partner and localizer of BRCA2 |
cancer |
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
cancer: other CRC-related |
|
PMS1 |
PMS1 postmeiotic segregation increased 1 (S. cerevisiae) |
cancer: other CRC-related |
|
PMS2 |
PMS2 postmeiotic segregation increased 2 (S. cerevisiae) |
cancer: CRC |
|
POLD1 |
polymerase (DNA directed), delta 1, catalytic subunit |
cancer: CRC |
|
POLE |
polymerase (DNA directed), epsilon, catalytic subunit |
cancer: CRC |
|
PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
cancer: multiple endocrine neoplasia |
|
PTCH1 |
patched 1 |
cancer: CRC |
|
PTEN |
phosphatase and tensin homolog |
cancer: CRC |
|
PTPN11 |
protein tyrosine phosphatase, non-receptor type 11 |
cancer |
|
RAD50 |
RAD50 homolog (S. cerevisiae) |
cancer |
|
RAD51 |
RAD51 recombinase |
cancer |
|
RAD51C |
RAD51 paralog C |
cancer |
|
RAD51D |
RAD51 paralog D |
cancer |
|
RET |
ret proto-oncogene |
cancer: multiple endocrine neoplasia |
|
SDHB |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
cancer: multiple endocrine neoplasia |
|
SDHC |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa |
cancer: multiple endocrine neoplasia |
|
SDHD |
succinate dehydrogenase complex, subunit D, integral membrane protein |
cancer: multiple endocrine neoplasia |
|
SFXN4 |
sideroflexin 4 |
cancer |
|
SMAD4 |
SMAD family member 4 |
cancer: CRC |
|
SPRED1 |
sprouty-related, EVH1 domain containing 1 |
cancer: NF |
|
STK11 |
serine/threonine kinase 11 |
cancer: CRC |
|
TGFB1 |
transforming growth factor, beta 1 |
cancer: other CRC-related |
|
TP53 |
tumor protein p53 |
cancer: CRC |
|
TP73 |
tumor protein p73 |
cancer: other CRC-related |
|
TWSG1 |
twisted gastrulation BMP signaling modulator 1 |
cancer |
|
TYMS |
thymidylate synthetase |
cancer: other CRC-related |
|
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
cancer |
|
UIMC1 |
ubiquitin interaction motif containing 1 |
cancer |
|
VHL |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
cancer: multiple endocrine neoplasia, kidney |
|
XRCC2 |
X-ray repair complementing defective repair in Chinese hamster cells 2 |
cancer |
|
XRCC3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
cancer |
